IP Library Granted Patent US 10,709,810
Granted Patent B2
US 10,709,810 · App. 15/159,220 · Granted Jul 14, 2020

Processed adipose tissue

Inventors: Wenquan Sun (Warrington, PA); Xianghong Liu (Hillsborough, NJ)
Assignee: LifeCell Corporation
A61L27/3604A61F2/12A61K35/35A61L27/3695A61L2430/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,709,810
App. No.
15/159,220
Granted
Jul 14, 2020
Kind
B2
Abstract

The present disclosure provides tissue products produced from adipose-containing tissues, as well as methods for producing such tissue products. The tissue products can include decellularized and partially de-fatted tissues. In addition, the present disclosure provides systems and methods for using such products.

Claims (23)

1. A method of producing a tissue product, comprising:

providing a sheet of tissue comprising adipose-containing transitional dermis;

treating the sheet of tissue to remove substantially all cellular material from the tissue; and

processing the sheet of tissue to partially remove lipid components such that the tissue product retains at least about 35% lipid content as a percentage of the overall tissue product by mass following processing.

2. The method of claim 1 , wherein the sheet of tissue comprises about 40-90% lipid content as a percentage of the overall tissue product by mass prior to processing.

3. The method of claim 1 , wherein substantially all cellular material is removed using one or more detergents.

4. The method of claim 3 , wherein the one or more detergents comprise at least a polyethylene glycol, Tris[2-(dimethylamino)ethyl]amine, sodium dodecyl sulfate, sodium deoxycholate, and polyoxyethylene (20) sorbitan mono-oleate.

5. The method of claim 1 , wherein processing the sheet of tissue to partially remove lipid components comprises exposing the sheet of tissue to an elevated temperature of about 40-50° C., to ultrasonic energy, or a combination of the elevated temperature and the ultrasonic energy.

6. The method of claim 1 , wherein the tissue product comprises at least about 3% extracellular matrix components as a percentage of the overall tissue product by mass following processing.

7. The method of claim 1 , further comprising exposing the tissue product to E-beam radiation.

8. The method of claim 1 , wherein processing the sheet of tissue to partially remove lipid components includes processing the sheet of tissue such that the tissue product contains between 35% and 50% lipid content as a percentage of the overall tissue product by mass.

9. A tissue product, comprising:

a sheet of decellularized adipose-containing transitional dermal matrix,

wherein a portion of lipid components have been removed from the sheet of decellularized adipose-containing transitional dermal matrix such that the tissue product retains at least about 35% lipid content as a percentage of the overall tissue product by mass.

10. The tissue product of claim 9 , wherein the tissue product has at most about 70% lipid content as a percentage of the overall tissue product by mass.

11. The tissue product of claim 9 , wherein the tissue product has at least about 3% extracellular matrix components as a percentage of the overall tissue product by mass.

12. A method of treatment comprising:

selecting a tissue site in a patient; and

implanting the tissue product of claim 9 on or into the tissue site.

13. The method of claim 12 , wherein the tissue site comprises adipose tissue or soft tissue.

14. The method of claim 12 , wherein the tissue site comprises a breast.

15. The method of claim 14 , wherein the tissue product is implanted to augment a tissue site.

16. The method of claim 12 , wherein the tissue site is a breast, a face, a buttock, an abdomen, a hip, or a thigh.

Assignments (6)
RELEASE OF SECURITY INTEREST 040098/0268 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0554 →
RELEASE OF SECURITY INTEREST 037845/0497 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0603 →
RELEASE OF SECURITY INTEREST 040291/0237 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0702 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2016
From: SUN, WENQUAN; LIU, XIANGHONG
To: LIFECELL CORPORATION
Reel/Frame 038781/0185 →
Continuity (3)
Continuation 14036369 · Sep 25, 2013
Provisional Application 61705789 · Sep 26, 2012
Related Publication 20160256606A1 · Sep 8, 2016
Cited By (4)
US 12,351,620 US 12,351,621 US 12,447,180 US 12,629,453